Alex Chompff

Pulmonary artery enlargement observed during bevacizumab therapy in KRAS-mutant colon cancer

Skip to content The CRC Digest Pulmonary artery enlargement observed during bevacizumab therapy in KRAS-mutant colon cancer A retrospective study of 150 patients with KRAS-mutant colon cancer investigated whether serial thoracic CT demonstrates progressive enlargement of the main pulmonary artery during bevacizumab-based chemotherapy. (Cancer Chemother Pharmacol) This content is informational

Subscribe to The CRC Digest

Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe